Good luck to all the holders of Mesoblast. I hope it goes up ten fold from here.
- Forums
- ASX - By Stock
- MSB
- Ann: 83% Survival in COVID-19 ARDS Patients with Remestemcel-L
Ann: 83% Survival in COVID-19 ARDS Patients with Remestemcel-L, page-90
-
-
- There are more pages in this discussion • 758 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
99.5¢ |
Change
0.005(0.51%) |
Mkt cap ! $1.158B |
Open | High | Low | Value | Volume |
99.5¢ | $1.02 | 98.5¢ | $1.597M | 1.591M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
28 | 118939 | 99.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.00 | 52264 | 33 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
25 | 104997 | 0.995 |
20 | 150391 | 0.990 |
13 | 166919 | 0.985 |
11 | 168256 | 0.980 |
3 | 502841 | 0.975 |
Price($) | Vol. | No. |
---|---|---|
1.000 | 54452 | 45 |
1.005 | 61094 | 12 |
1.010 | 141478 | 13 |
1.015 | 114450 | 10 |
1.020 | 148594 | 13 |
Last trade - 13.05pm 15/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online